|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 9/00 | (2006.01) |
| A61P 19/08 | (2006.01) | ||
| A61K 47/20 | (2006.01) | ||
| A61K 39/395 | (2006.01) | ||
| A61P 19/10 | (2006.01) | ||
| A61P 29/00 | (2006.01) | ||
| C07K 16/22 | (2006.01) | ||
| A61K 47/18 | (2017.01) | ||
| A61K 9/08 | (2006.01) | ||
| A61K 47/40 | (2006.01) |
| (11) | Number of the document | 3426294 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17710208.4 |
| Date of filing the European patent application | 2017-03-09 | |
| (97) | Date of publication of the European application | 2019-01-16 |
| (45) | Date of publication and mention of the grant of the patent | 2023-05-17 |
| (46) | Date of publication of the claims translation | 2023-06-26 |
| (86) | Number | PCT/EP2017/055594 |
| Date | 2017-03-09 |
| (87) | Number | WO 2017/153541 |
| Date | 2017-09-14 |
| (30) | Number | Date | Country code |
| 201604124 | 2016-03-10 | GB |
| (72) |
YATES, Andrew Jeffrey , AU
CLIPSTONE, James Gregory , GB
|
| (73) |
UCB Biopharma SRL ,
Allée de la Recherche 60, 1070 Brussels,
BE
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Farmacinė vaisto forma, apimanti antikūną, ciklodekstriną ir metioniną |
| PHARMACEUTICAL FORMULATION COMPRISING ANTIBODY, CYCLODEXTRIN AND METHIONINE |
| Payment date | Validity (years) | Amount | |
| 2026-02-23 | 10 | 231.00 EUR |
| 2027-03-09 |